SEC Filing Summary for Thomas J. Falk - AbbVie Inc.

This filing details a transaction by Thomas J. Falk, a director at AbbVie Inc. On May 8, 2026, Mr. Falk acquired 1,118 units of restricted stock under the company's incentive program. These units are set to be paid out on a one-to-one basis in shares of AbbVie common stock. The payout will occur on the earliest of Mr. Falk's separation from service, death, or a change in control, as defined by the program. Following this transaction, Mr. Falk has 2,321 shares. Additionally, the filing notes that 3,000 shares are held indirectly through a limited partnership jointly controlled by Mr. Falk and his spouse, of which he disclaims beneficial ownership except to the extent of his pecuniary interest.